Hsin-Ling Yang Selected Research

Coenzymes (Enzyme Cofactors)

9/2021	Coenzyme Q0, a novel quinone derivative of Antrodia camphorata, induces ROS-mediated cytotoxic autophagy and apoptosis against human glioblastoma cells in vitro and in vivo.
5/2019	Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
1/2019	The in vitro and in vivo depigmenting activity of Coenzyme Q10 through the down-regulation of α-MSH signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in UVA-irradiated skin keratinocytes.
1/2017	Antitumor properties of Coenzyme Q0 against human ovarian carcinoma cells via induction of ROS-mediated apoptosis and cytoprotective autophagy.
1/2017	Coenzyme Q0 Enhances Ultraviolet B-Induced Apoptosis in Human Estrogen Receptor-Positive Breast (MCF-7) Cancer Cells.
2/2016	Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hsin-Ling Yang Research Topics

Disease

20	Neoplasms (Cancer) 12/2021 - 08/2008
12	Inflammation (Inflammations) 01/2022 - 09/2011
9	Neoplasm Metastasis (Metastasis) 12/2021 - 04/2012
9	Melanoma (Melanoma, Malignant) 09/2021 - 01/2012
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2012
7	Atherosclerosis 08/2017 - 01/2006
6	Carcinoma (Carcinomatosis) 09/2021 - 03/2012
6	Hemolysis 10/2017 - 06/2002
5	Leukemia 01/2018 - 08/2004
4	Wounds and Injuries (Trauma) 03/2022 - 01/2017
4	Triple Negative Breast Neoplasms 12/2021 - 01/2017
4	Breast Neoplasms (Breast Cancer) 05/2019 - 07/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2019
2	Necrosis 09/2021 - 05/2017
2	Infections 01/2021 - 06/2011
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 08/2017
2	Stomach Neoplasms (Stomach Cancer) 09/2020 - 06/2012
2	Fibrosis (Cirrhosis) 01/2019 - 01/2010
2	Lung Neoplasms (Lung Cancer) 01/2017 - 02/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2012 - 06/2011
1	Glioblastoma (Glioblastoma Multiforme) 09/2021
1	Colitis 01/2021
1	Carcinogenesis 01/2021
1	Pancreatitis 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2019

Drug/Important Bio-Agent (IBA)

11	AntioxidantsIBA 01/2021 - 01/2006
8	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2012
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2002
7	flavokawain BIBA 01/2021 - 03/2012
7	Chalcone (Benzalacetophenone)IBA 01/2021 - 03/2012
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 12/2006
6	Coenzymes (Enzyme Cofactors)IBA 09/2021 - 02/2016
6	CateninsIBA 05/2019 - 01/2012
6	2,2'-azobis(2-amidinopropane) (ABAP)IBA 10/2017 - 06/2002
5	quinone (benzoquinone)IBA 01/2022 - 02/2016
5	Cytochromes c (Cytochrome c)IBA 12/2014 - 01/2012
4	Free RadicalsIBA 10/2017 - 09/2011
4	Gallic AcidIBA 05/2013 - 01/2008
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 07/2007
3	Cadherins (E-Cadherin)IBA 05/2019 - 01/2019
3	ChalconesIBA 01/2019 - 03/2012
3	LipidsIBA 10/2017 - 06/2002
3	Caspase 9IBA 12/2014 - 01/2012
3	Humic SubstancesIBA 12/2014 - 08/2004
2	Annexin A5IBA 09/2021 - 05/2017
2	thiazolyl blueIBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 02/2010
2	Melanins (Melanin)IBA 01/2020 - 01/2019
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2020 - 01/2019
2	LipopolysaccharidesIBA 01/2020 - 01/2015
2	LuciferasesIBA 05/2019 - 02/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 06/2012
2	Fas Ligand Protein (Fas Ligand)IBA 01/2019 - 04/2014
2	SmokeIBA 08/2017 - 11/2007
2	lucidoneIBA 01/2017 - 09/2013
2	Estrogen ReceptorsIBA 01/2017 - 01/2012
2	Cyclin AIBA 04/2014 - 03/2012
2	Cyclin D1IBA 04/2014 - 08/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2014 - 01/2010
2	Superoxide DismutaseIBA 09/2011 - 01/2008
2	perhydroxyl radicalIBA 09/2006 - 06/2002
1	Isoflurane FDA LinkGeneric 03/2022
1	naringinIBA 03/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021
1	Sirolimus (Rapamycin)FDA Link 12/2021
1	TOR Serine-Threonine KinasesIBA 12/2021
1	Metalloproteases (Metalloproteinases)IBA 12/2021
1	bisdemethoxycurcuminIBA 12/2021
1	Twist-Related Protein 1IBA 12/2021
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2021
1	AzoxymethaneIBA 01/2021
1	SodiumIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 10/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2020
1	Intercalating AgentsIBA 09/2020
1	Protein Kinase CIBA 01/2020
1	ectoineIBA 01/2020
1	Microphthalmia-Associated Transcription FactorIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	tyrosinase-related protein-1IBA 01/2020
1	Cyclic AMP (AMP, Cyclic)IBA 01/2020
1	Cholecystokinin (Pancreozymin)IBA 01/2020
1	flavokawain AIBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2019
1	Hematoxylin (Haematoxylon)IBA 05/2019
1	Ethanol (Ethyl Alcohol)IBA 02/2019
1	UbiquinoneIBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	coenzyme Q10 (CoQ10)IBA 01/2019
1	Beclin-1IBA 01/2019

Therapy/Procedure

1	Therapeutics 12/2021
1	Traditional Medicine (Folk Remedies) 01/2019